131 results
Page 5 of 7
8-K
EX-99
3e1uubvyb5m9wut
20 Apr 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-4.3
fzgvsfhorw8
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
8-K
EX-4.1
80lfbyb6 d5bu
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
8-K
EX-10.1
s8ra yjxvgp1kz
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
424B5
336bm
13 Jan 11
Prospectus supplement for primary offering
12:00am
8-K
EX-4.2
cp6i7
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
424B5
i0ny63ulwhi5gr
23 Dec 10
Prospectus supplement for primary offering
12:00am
8-K
EX-4.1
ukh7m1
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
bjkf1p1 hqpd
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
S-3/A
97j5x4o6dkkmnjx 526
12 Jul 10
Shelf registration (amended)
12:00am